Despite experimental evidence supporting the therapeutic effect of GSK3β inhibition, none of GSK3β inhibitors was approved for treatment of diseases such as diabetes mellitus, Alzheimer's disease, and cancer. This evidence concerns the gene GSK3B and cancer.